DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/13817
Title: A prospective study of Salvia miltiorrhiza and Rhizoma chuanxiong preparation in the treatment of hypoparathyroidism after total thyroidectomy
Authors: Qian, XiaoYu
Tang, Jian
Chu, Yongquan
Chen, Liang
Chen, Ziqiang
Li, Lin
Keywords: Total thyroidectomy
hypoparathyroidism
hypocalcemia
Salvia miltiorrhiza
Rhizoma chuanxiong
Issue Date: 1-Nov-2021
Publisher: Karachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.
Citation: Qian, X., Tang, J., Chu, Y., Chen, L., Chen, Z., & Li, L. (2021). A prospective study of Salvia miltiorrhiza and Rhizoma chuanxiong preparation in the treatment of hypoparathyroidism after total thyroidectomy. Pakistan Journal of Pharmaceutical Sciences, 34(6 (Special)), 2385-2389.
Abstract: This study aimed to investigate the clinical efficacy of Salvia miltiorrhiza and Rhizoma chuanxiong preparation on hypoparathyroidism. A total of 100 patients with hypoparathyroidism after total thyroidectomy were erolled, they were divided into the observation group (n=50), Salvia miltiorrhiza and Rhizoma chuanxiong preparation were added on the basis of traditional treatment. The control group (n=50), were treated with traditional treatment. To analyze the therapeutic effect of Salvia miltiorrhiza and Rhizoma chuanxiong preparation on hypoparathyroidism. After follow-up, the recovery time of parathyroid function in the observation group was significantly shorter than the control (P<0.05). No permanent hypoparathyroidism in the observation group and 4 cases in the control, which was statistically significant (P<0.05). The serum PTH in the observation group was significantly higher than the control on the 7th, 30th day, 3rd and 6th month. The level of serum calcium in the observation group was significantly higher than the control on the 3rd, 7th and 30th day (P<0.05). Salvia miltiorrhiza and Rhizoma chuanxiong preparation has obvious effects on the treatment of hypoparathyroidism and has low adverse reactions, which is worthy of clinical application.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/13817
ISSN: 1011-601X
Appears in Collections:Issue 6 (Special)

Files in This Item:
File Description SizeFormat 
1-9355-SP.htm140 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.